Full Text View
Tabular View
No Study Results Posted
Related Studies
A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease
This study is currently recruiting participants.
Verified February 2012 by Stempeutics Research Pvt Ltd
Study NCT01484574   Information provided by Stempeutics Research Pvt Ltd

First Received on November 27, 2011.   Last Updated on February 10, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Critical Limb Ischemia
Buerger's Disease
Additional conditions recognized in this trial
Ischemia
Thromboangiitis Obliterans
More general conditions related to this trial
Arterial Occlusive Diseases
Cardiovascular Diseases
Pathologic Processes
Vascular Diseases
Vasculitis
Interventions listed in this trial
Allogeneic Mesenchymal Stem Cells
Standard protocol of care
Sponsors listed in this trial
Stempeutics Research Pvt Ltd


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services